• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Watson Pharmaceuticals

Watson Pharmaceuticals

  1. Rate Hikes? Not in 2015

    Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL. The pain patch is one of the ...

  2. Stockton is Bankrupt: Now What?

    Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.

  3. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.